Altri amino amino prutetti per u bond di disuffide

NO

Prudutti

Cas stessu

Applicazione

Indicatore di qualità chjave

PURITUZA

Isomeru

Impurità specifica

* Max1

Umidità

1

Fmoc-cys (ACM) -oh

86060-81-3

Bond Bond

≥99.0%

≤,1%

≤,1%

≤0,2%

≤,0%

2

Fmoc-cys (mmt) -oh

177882-21-7

Bond Bond

≥98.0%

≤0,2%

≤0,3%

≤0,5%

≤,0%

3

Fmoc-cys (4-allylbutyrate) -oh

/

Bond Bond

≥98.0%

≤0,2%

≤0,3%

≤0,5%

≤,0%

4

MPA (TRT) -Oh

27144-18-9

Fine di sequenza

≥99.5%

/

≤,1%

≤0,2%

≤,0%

5

Fmoc-thr (tbu) -ol

189337-28-8

Ocquetooide

≥97,0%

≤0,3%

≤0,5%

≤,0%

≤,0%

6

Fmoc-d-arg (PBF) -o

187618-60-6

Desmopressin

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤2,0%

7

Fmoc-gly-gly-oh

35665-38-4

BALIVIIDIN

≥99.5%

/

≤,1%

≤0,2%

≤,0%

8

Fmoc-gly-gly-oh

170941-79-4

Terlipressin

≥99.5%

/

≤,1%

≤0,2%

≤,0%

9

Fmoc-gly-gly-gly-oh

/

BALIVIIDIN

≥99.5%

/

≤,1%

≤0,2%

≤,0%

10

Fmoc-gly-asp (tbu) -oh

/

BALIVIIDIN

≥99.5%

/

≤0.15%

≤0,2%

≤,0%

11

BOC-CYS (TRT) -Oh

21947-98-8

Fine di sequenza

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

12

BOC-arg (PBF) -o

200124-22-7

Fine di sequenza

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

13

BOC-Ala-Oh

15761-38-3

Fine di sequenza

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

14

BOC-D-PHE-OH

18942-49-9

Fine di sequenza

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

15

Boc-gly-oh

4530-20-5

Fine di sequenza

≥99.5%

/

≤,1%

≤0,2%

≤,0%

16

BOC-Lys (BOC) -OH.DCHA

15098-69-8

Fine di sequenza

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

17

BOC-Ser (TBU) -Oh

7738-22-9

Fine di sequenza

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

18

BOC-THR (TBU) -Oh

13734-40-2

Fine di sequenza

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

19

BOC-D-Ala-Oh

7764-95-6

Fine di sequenza

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

20

BOC-met-oh

2488-15-5

Fine di sequenza

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

21

BOC-TYR (TBU) -Oh

47375-34-8

Fine di sequenza

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

22

BOC-D-ARG (PDF) -Oh

187618-60-6

Fine di sequenza

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

23

BOC-ASP (OTBU) -OH.DCHA

1913/12/8

Fine di sequenza

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

24

Fmoc-homoarg (pbf) -oh

1159680-21-3

EPPIACTID

≥98.5%

≤0,2%

/

≤0,5%

≤2,0%

25

Fmoc-asp-otubu

129460-09-9

TERPALFASIN

≥99.5%

≤,1%

≤,1%

≤0,2%

≤,0%

26

Fmoc-tyr (me) -oh

77128-72-4

Carbetocinu

≥98.5%

≤0,2%

≤0,3%

≤0,5%

≤,0%

27

Fmoc-orn (boc) -oh

109425-55-0

À l'atosiban

Omnipressin

DaptommyCin

≥99.5%

≤,1%

≤,1%

≤0,2%

≤2,0%

28

Fmoc-D-Tyr (et) -oh

162502-65-0

À l'atosiban

≥99.5%

≤,1%

≤,1%

≤0,2%

≤,0%

29

Fmoc-asp (oall) -oh

146982-24-3

Melanotan

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

30

Ac-nle-oh

15891-49-3

Melanotan

≥99.0%

/

≤0,3%

≤0,3%

≤,0%

31

Fmoc-nle-oh

77284-32-3

Melanotan

AFAMELATUD

≥99.0%

/

≤0,3%

≤0,3%

≤,0%

32

Ac-glu (otbu) -oh

84192-88-1

CLIRELINE

Acetyl octepteptide-3

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

33

AC-Β-Ala-Oh · DCHA

/

Acetil tetrapptide-5

≥99.0%

/

≤0,3%

≤0,3%

≤,0%

34

Fmoc-ß-Ala-oh

35737-10-1

Acetil tetrapptide-5

≥99.5%

/

≤,1%

≤0,2%

≤,0%

35

Fmoc-ip (tbu) -oh

122996-47-8

Icatibant

≥98.0%

≤0,2%

≤0,3%

≤0,5%

≤,0%

36

Fmoc-thi-oh

130309-35-2

Icatibant

≥98.0%

≤0,2%

≤0,3%

≤0,5%

≤,0%

37

Fmoc-d-tic-oh

130309-33-0

Icatibant

≥98.0%

≤0,2%

≤0,3%

≤0,5%

≤,0%

38

Fmoc-oic-oh

130309-37-4

Icatibant

≥98.0%

≤0,2%

≤0,3%

≤0,5%

≤,0%

39

Boc-Sar-oh

13734-36-6

Saralasin

≥98.0%

≤0,2%

≤0,3%

≤0,5%

≤,0%

40

Fmoc-sar-oh

77128-70-2

Saralasin

≥98.0%

≤0,2%

≤0,3%

≤0,5%

≤,0%

41

Fmoc-tyr (so3na) -oh2O

106864-37-3

Sintade

≥98.0%

≤0,2%

≤0,3%

≤0,5%

≤,0%

42

Fmoc-d-asp (otbu) -oh

112883-39-3

DaptommyCin

≥98.5%

≤0,2%

≤0,3%

≤0,5%

≤,0%

43

AC-ser (TBU) -Oh

77285-09-7

AFAMELATUD

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%

44

BOC-Homocys (TRT) -Oh

201419-16-1

Depreotide

≥98.0%

≤0,2%

≤0,3%

≤0,5%

≤,0%

45

FMOC-Homocys (TRT) -Oh

167015-23-8

Depreotide

≥98.0%

≤0,2%

≤0,3%

≤0,5%

≤,0%

46

Fmoc-Dab-oh

161420-87-7

Serpente Venom

≥99.0%

≤0,2%

≤0,3%

≤0,3%

≤,0%